Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

NRXP — NRX Pharmaceuticals, Inc. SEC Filings | FilingIndex

NRXPNasdaq

NRX Pharmaceuticals, Inc.

Pharmaceutical Preparations · DE · CIK 1719406

NRx Pharmaceuticals develops novel therapeutics for central nervous system disorders, focusing on neuroplasticity

+ Watch View on EDGAR ↗

$164M

Market cap

$4.09

Last close

+2.3%

1D

+8.8%

5D

750K

Volume

Price · last 40 sessions+36.3%

May 4L $2.82 · H $4.62Jun 30

240

Total filings

Jun 4, 2026

Last filing

12/31

Fiscal year end

All 8-K · 124 10-Q · 25 424B5 · 15 DEF 14A · 13 425 · 10 10-K · 9 SC 13G · 8 DEFA14A · 7

10-QFORM 10-QMay 15, 2026 10-QFORM 10-QNov 14, 2025 10-QFORM 10-QAug 18, 2025 10-QFORM 10-QMay 15, 2025 10-QFORM 10-QNov 14, 2024 10-Q

Similar companies

Comparable business profile · signals at a glance

ATAIAtaiBeckley Inc.$1.4B-1.7%DFTXDefinium Therapeutics, Inc.🔥$2.7B+1.1%STIMNeuronetics, Inc.$92.6M-4.4%GHRSGH Research PLC$1.4B-5.7%DWTXDogwood Therapeutics, Inc.

FORM 10-Q

Aug 14, 2024

10-Q10-QMay 14, 2024

10-Q10-QNov 14, 2023

10-Q10-QAug 14, 2023

10-Q10-QMay 15, 2023

10-Q10-QNov 14, 2022

10-Q10-QAug 15, 2022

10-Q10-QMay 16, 2022

10-Q10-QNov 15, 2021

10-Q10-QAug 16, 2021

10-Q10-QMay 21, 2021

10-QQUARTERLY REPORTNov 16, 2020

10-QQUARTERLY REPORTAug 14, 2020

10-QQUARTERLY REPORTMay 15, 2020

10-QQUARTERLY REPORTNov 14, 2019

10-QQUARTERLY REPORTAug 14, 2019

10-QQUARTERLY REPORTMay 15, 2019

10-QQUARTERLY REPORTNov 8, 2018

10-QQUARTERLY REPORTAug 8, 2018

10-QQUARTERLY REPORTMay 15, 2018

$51.8M

-9.6%

SUPNSUPERNUS PHARMACEUTICALS, INC.$2.6B-0.6%